Back to Search
NITHYA RAMNATH, MD
MD
Medical Oncology Physician
NPI: 1326029562Individual
Specialties, Licenses & Credentials
Hematology (Internal Medicine) Physician
Internal Medicine — Hematology
Code: 207RH0000X
4301064400(MI)
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
214751-1(NY)4301064400(MI)
Internal Medicine Physician
Internal Medicine
Code: 207R00000X
4301064400(MI)
Research & Publications (20)
Progress in the treatment of metastatic non-small-cell lung cancer: slow but steady!
PMID 19632945·Clin Lung Cancer·2009
8-other
Lung cancer xenografting alters microRNA profile but not immunophenotype.
PMID 19523437·Biochem Biophys Res Commun·2009
7-preclinical
Apoptosis-related (survivin, Bcl-2), tumor suppressor gene (p53), proliferation (Ki-67), and non-receptor tyrosine kinase (Src) markers expression and correlation with clinicopathologic variables in 60 thymic neoplasms.
PMID 19318677·Chest·2009
8-other
Treatment outcomes of different prognostic groups of patients on cancer and leukemia group B trial 39801: induction chemotherapy followed by chemoradiotherapy compared with chemoradiotherapy alone for unresectable stage III non-small cell lung cancer.
PMID 19652624·J Thorac Oncol·2009
4-observational
Eukaryotic initiation factor-4E and cyclin D1 expression associated with patient survival in lung cancer.
PMID 19289374·Clin Lung Cancer·2009
8-other
Metachronous and synchronous presentation of acute myeloid leukemia and lung cancer.
PMID 19181380·Leuk Res·2009
8-other
Thoracoscopic organ suffusion for regional lung chemotherapy (preliminary results).
PMID 19632379·Ann Thorac Surg·2009
3-trial
Erlotinib for metastatic non-small-cell lung cancer: first-, second- or third-line setting - does it matter ? A single-institution experience.
PMID 19122466·Oncology·2009
8-other
In vitro and in vivo evaluation of combined calcitriol and cisplatin in dogs with spontaneously occurring tumors.
PMID 18246349·Cancer Chemother Pharmacol·2008
3-trial
Malignant pleural mesothelioma after household exposure to asbestos.
PMID 18955439·J Clin Oncol·2008
5-case
Expression and mutational analysis of MET in human solid cancers.
PMID 18709663·Genes Chromosomes Cancer·2008
8-other
Scheduled administration of low dose irinotecan before gemcitabine in the second line therapy of non-small cell lung cancer: a phase II study.
PMID 18594219·Anticancer Drugs·2008
3-trial
Up-regulation of peroxiredoxin 1 in lung cancer and its implication as a prognostic and therapeutic target.
PMID 18413821·Clin Cancer Res·2008
8-other
Wood dust exposure and the risk of upper aero-digestive and respiratory cancers in males.
PMID 18182588·Occup Environ Med·2008
8-other
High superoxide dismutase and low glutathione peroxidase activities in red blood cells predict susceptibility of lung cancer patients to radiation pneumonitis.
PMID 17189833·Free Radic Biol Med·2007
7-preclinical
Hormone replacement therapy as a risk factor for non-small cell lung cancer: results of a case-control study.
PMID 18493157·Oncology·2007
8-other
Elevated peroxiredoxin 1, but not NF-E2-related factor 2, is an independent prognostic factor for disease recurrence and reduced survival in stage I non-small cell lung cancer.
PMID 17606720·Clin Cancer Res·2007
8-other
What did you think of the hematology/oncology rotation? A survey of internal medicine residents.
PMID 17570810·J Cancer Educ·2007
8-other
Pneumonectomy for bronchogenic carcinoma: analysis of factors predicting survival.
PMID 17462408·Ann Thorac Surg·2007
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1500 EAST MEDICAL CENTER DR, B1 FLOOR CANCER & GERIATRICS CTR RECP C
ANN ARBOR, MI 48109 - Phone
- (734) 647-8902
Quick Facts
- NPI
- 1326029562
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 4
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile